NAGE
Niagen Bioscience Inc
NASDAQHealthcareBiotechnologyUS
Rating:B+
Company Profile
CEO
Robert N. Fried
IPO Date
2015-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Niagen Bioscience Inc
CEO
Robert N. Fried
IPO Date
2015-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 20,000 |
| $2.61 |
| 24 Feb 2026 | Lopez Carlos Luis | SVP, General Counsel | A-Award | Acquired | 41,420 | $4.94 |
| 24 Feb 2026 | Pamir Ozan | Chief Financial Officer | A-Award | Acquired | 62,131 | $4.94 |
| 24 Feb 2026 | Fried Robert N | director, officer: Chief Executive Officer | A-Award | Acquired | 503,937 | $4.94 |
| 17 Nov 2025 | Pamir Ozan | Chief Financial Officer | P-Purchase | Acquired | 4,464.962 | $6.81 |
| 17 Nov 2025 | Pamir Ozan | Chief Financial Officer | P-Purchase | Acquired | 2,220.443 | $6.85 |
| 3 Jul 2025 | Shahbazi Hamed | director | A-Award | Acquired | 20,000 | $14.13 |
| 26 Jun 2025 | YU Wing Tak Wendy | director | A-Award | Acquired | 20,000 | $14.13 |
| 26 Jun 2025 | Patrick Kristin | director | A-Award | Acquired | 20,000 | $14.13 |